Javier Valdivia Selected Research

Therapeutics

4/2024	Spatially preserved multi-region transcriptomic subtyping and biomarkers of chemoimmunotherapy outcome in extensive-stage small cell lung cancer.
1/2022	Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy.
1/2020	Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial.
1/2018	Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Javier Valdivia Research Topics

Disease

4	Neoplasms (Cancer) 04/2024 - 01/2020
4	Melanoma (Melanoma, Malignant) 01/2024 - 12/2014
4	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2019
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2024 - 01/2020
2	Disease Progression 01/2020 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 03/2012
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Fever (Fevers) 01/2020
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2020
1	Inflammation (Inflammations) 11/2019
1	Neutropenia 03/2012
1	Exanthema (Rash) 03/2012

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2021
2	PM 01183IBA 12/2020 - 01/2020
1	Messenger RNA (mRNA)IBA 04/2024
1	AntigensIBA 01/2022
1	PlatinumIBA 12/2020
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	CytokinesIBA 11/2019
1	FibrinIBA 11/2019
1	CTLA-4 AntigenIBA 12/2014
1	Monoclonal AntibodiesIBA 12/2014
1	IpilimumabIBA 12/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2012
1	TransferasesIBA 03/2012

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2021 - 03/2012
4	Therapeutics 04/2024 - 01/2018
1	Aftercare (After-Treatment) 01/2022
1	Intravenous Infusions 01/2020
1	Radiotherapy 01/2020
1	Chemoradiotherapy 01/2020